Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Early loss of Fhit in the respiratory tract of rodents exposed to environmental cigarette smoke.

D'Agostini F, Izzotti A, Balansky R, Zanesi N, Croce CM, De Flora S.

Cancer Res. 2006 Apr 1;66(7):3936-41.

2.

Chelators as antidotes of metal toxicity: therapeutic and experimental aspects.

Blanusa M, Varnai VM, Piasek M, Kostial K.

Curr Med Chem. 2005;12(23):2771-94. Review.

PMID:
16305472
4.

A mouse model of the fragile gene FHIT: From carcinogenesis to gene therapy and cancer prevention.

Zanesi N, Pekarsky Y, Croce CM.

Mutat Res. 2005 Dec 11;591(1-2):103-9. Epub 2005 Aug 8. Review.

PMID:
16085127
5.

Modulation of multigene expression and proteome profiles by chemopreventive agents.

Izzotti A, Bagnasco M, Cartiglia C, Longobardi M, Camoirano A, Tampa E, Lubet RA, De Flora S.

Mutat Res. 2005 Dec 11;591(1-2):212-23. Epub 2005 Aug 3.

PMID:
16083920
6.

Lung cancer susceptibility in Fhit-deficient mice is increased by Vhl haploinsufficiency.

Zanesi N, Mancini R, Sevignani C, Vecchione A, Kaou M, Valtieri M, Calin GA, Pekarsky Y, Gnarra JR, Croce CM, Huebner K.

Cancer Res. 2005 Aug 1;65(15):6576-82.

7.

Induction and modulation of lung tumors: genomic and transcriptional alterations in cigarette smoke-exposed mice.

De Flora S, Izzotti A, D'Agostini F, Bennicelli C, You M, Lubet RA, Balansky RM.

Exp Lung Res. 2005 Jan-Feb;31(1):19-35.

PMID:
15765917
8.

Budesonide exerts its chemopreventive efficacy during mouse lung tumorigenesis by modulating gene expressions.

Yao R, Wang Y, Lemon WJ, Lubet RA, You M.

Oncogene. 2004 Oct 7;23(46):7746-52.

PMID:
15361829
9.

Tumor profile of novel p53 heterozygous Tg.AC (v-Ha-ras) bitransgenic mice treated with benzo(a)pyrene and fed dietary N-acetyl-L-cysteine (NAC).

Martin KR, Jokinen MP, Honeycutt HP, Quinn A, Kari FW, Barrett JC, French JE.

Toxicol Sci. 2004 Oct;81(2):293-301. Epub 2004 Jul 14.

PMID:
15254344
10.
11.

Effect of chemopreventive agents on separate stages of progression of benzo[alpha]pyrene induced lung tumors in A/J mice.

Estensen RD, Jordan MM, Wiedmann TS, Galbraith AR, Steele VE, Wattenberg LW.

Carcinogenesis. 2004 Feb;25(2):197-201. Epub 2003 Oct 24.

PMID:
14578161
13.

Cancer and the FRA3B/FHIT fragile locus: it's a HIT.

Huebner K, Croce CM.

Br J Cancer. 2003 May 19;88(10):1501-6.

14.

Genomic and transcriptional alterations in mouse fetus liver after transplacental exposure to cigarette smoke.

Izzotti A, Balansky RM, Cartiglia C, Camoirano A, Longobardi M, De Flora S.

FASEB J. 2003 Jun;17(9):1127-9. Epub 2003 Apr 22.

PMID:
12709406
15.

FHIT: from gene discovery to cancer treatment and prevention.

Pekarsky Y, Zanesi N, Palamarchuk A, Huebner K, Croce CM.

Lancet Oncol. 2002 Dec;3(12):748-54. Review.

PMID:
12473516
16.

Prevention of mouse lung tumors by budesonide and its modulation of biomarkers.

Pereira MA, Li Y, Gunning WT, Kramer PM, Al-Yaqoub F, Lubet RA, Steele VE, Szabo E, Tao L.

Carcinogenesis. 2002 Jul;23(7):1185-92.

PMID:
12117777
17.

In vitro inhibition of the enzymatic activity of tumor suppressor FHIT gene product by carcinogenic transition metals.

Kowara R, Karaczyn AA, Fivash MJ Jr, Kasprzak KS.

Chem Res Toxicol. 2002 Mar;15(3):319-25.

PMID:
11896678
18.

The tumor spectrum in FHIT-deficient mice.

Zanesi N, Fidanza V, Fong LY, Mancini R, Druck T, Valtieri M, RĂ¼diger T, McCue PA, Croce CM, Huebner K.

Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10250-5. Epub 2001 Aug 21.

19.

Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking-related end-points.

De Flora S, Izzotti A, D'Agostini F, Balansky RM.

Carcinogenesis. 2001 Jul;22(7):999-1013. Review.

PMID:
11408342
20.

p53 Involvement in the control of murine hair follicle regression.

Botchkarev VA, Komarova EA, Siebenhaar F, Botchkareva NV, Sharov AA, Komarov PG, Maurer M, Gudkov AV, Gilchrest BA.

Am J Pathol. 2001 Jun;158(6):1913-9.

Supplemental Content

Support Center